University of Kansas Medical Center
Kansas City, Missouri, 64130, United States
Location status: Recruiting
NCT Number: NCT05732272
This study will evaluate the efficacy of extended bupropion(6 months) versus standard bupropion treatment (7 weeks) among African American daily smokers.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Phase 3
Kansas City, Missouri, 64130, United States
Location status: Recruiting
The primary objective of this study is to evaluate extended use of bupropion with the goal of enhancing abstinence in African American daily smokers, including the full spectrum of light, moderate, and heavy smokers. A two-arm, randomized design will be used to evaluate the efficacy of extended (6 months) bupropion treatment compared to standard (7 weeks) bupropion treatment. Baseline randomization stratified by gender and cpd (≤10, >10cpd) will assign participants (N=500) to receive extended treatment (EXT; 24 weeks of bupropion, n=250) or standard treatment (ST; 7 weeks of bupropion, n=250). All participants will receive culturally-relevant, individualized smoking cessation counseling, including support for medication adherence, and will be followed through Month 12.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
150 mg once daily for 3 days, then twice daily for the remainder of the treatment phase.
Time frame: Month 6
Participants receiving extended bupropion treatment will have significantly higher Month 6 verified point-prevalence abstinence than participants receiving standard bupropion treatment.
Time frame: Week 4
We will evaluate the concordance of a biological sample of bupropion level, observable pill count, and 3-day recall as measurements of medication adherence.
Contact information is provided by the study sponsor or research team.
University of Kansas Medical Center
Other
Acronym: (KISV)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07585357
Behavior, Health Behavior
Baltimore, Maryland, United States
View Trial DetailsNCT06584929
Behavior, Health Behavior
Minneapolis, Minnesota, United States
View Trial DetailsNCT07166120
Behavior, Health Behavior
St Louis, Missouri, United States
View Trial DetailsNCT06651684
Behavior, Chemically-Induced Disorders
Montreal, Quebec, Canada
View Trial Details